Albireo Pharma Inc. (NASDAQ: ALBO) stock closed at 22.89 per share at the end of the most recent trading day (a -18.37% change compared to the prior day closing price) with a volume of 2.04M shares and market capitalization of 414.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 90 people. Albireo Pharma Inc. CEO is Ronald H.W. Cooper.

The one-year performance of Albireo Pharma Inc. stock is -25.24%, while year-to-date (YTD) performance is -1.72%. ALBO stock has a five-year performance of 6.32%. Its 52-week range is between 20.3 and 37.86, which gives ALBO stock a 52-week price range ratio of 4.90%

Albireo Pharma Inc. currently has a PE ratio of -15.10, a price-to-book (PB) ratio of 3.12, a price-to-sale (PS) ratio of 14.21, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -11.98%, a ROC of -10.68% and a ROE of -19.77%. The company’s profit margin is 21.67%, its EBITDA margin is -48.90%, and its revenue ttm is $38.61 Million , which makes it $1.97 revenue per share.

Of the last four earnings reports from Albireo Pharma Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-2.02 for the next earnings report. Albireo Pharma Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Albireo Pharma Inc. is Strong Buy (1), with a target price of $73.75, which is +248.54% compared to the current price. The earnings rating for Albireo Pharma Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Albireo Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Albireo Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.60, ATR14 : 2.31, CCI20 : -253.46, Chaikin Money Flow : -0.21, MACD : -1.69, Money Flow Index : 26.78, ROC : -28.06, RSI : 26.08, STOCH (14,3) : 16.42, STOCH RSI : 0.00, UO : 34.76, Williams %R : -83.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Albireo Pharma Inc. in the last 12-months were: Jan P. Mattsson (Sold 1 008 shares of value $26 690 ), Jason G. Duncan (Option Excercise at a value of $396 365), Jason G. Duncan (Sold 19 268 shares of value $674 998 ), Martha Carter (Sold 526 shares of value $13 762 ), Michelle Graham (Sold 521 shares of value $13 725 ), Pamela Stephenson (Sold 2 369 shares of value $70 357 ), Patrick Taylor Horn (Sold 185 shares of value $5 811 ), Ronald H.W. Cooper (Option Excercise at a value of $229 762), Ronald H.W. Cooper (Sold 4 591 shares of value $121 697 ), Simon Nicolas Reade Harford (Sold 917 shares of value $26 297 )